Abstract:Background Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy. The mechanism underlying the crosstalk between long non-coding RNAs (lncRNAs) and N 6 -methyladenine (m6A) modification in GDM remain unclear. Methods We generated a lncRNA-mediated competitive endogenous RNA (ceRNA) network using comprehensive data from the Gene Expression Omnibus database, published data, and our preliminary findings. m6A-related lncRNAs were identified based on Pearson correlation coefficient (PCC) analysis using our previous profiles. An integrated pipeline was established to constructed a m6A-related subnetwork thereby predicting the potential effects of the m6A-related lncRNAs. Results The ceRNA network was composed of 16 lncRNAs, 17 microRNAs, 184 mRNAs, and 338 edges. Analysis with the Kyoto Encyclopedia of Genes and Genomes database demonstrated that genes in the ceRNA network were primarily involved in the development and adverse outcomes of GDM, such as those in the fatty acid-metabolism pathway, the peroxisome proliferator-activated receptor signaling pathway, and thyroid hormone signaling pathway. Four m6A-related lncRNAs were involved in the ceRNA network, including LINC00667 , LINC01087 , AP000350.6 , and CARMN . The m6A-related subnetwork was generated based on these four lncRNAs, their ceRNAs, and their related m6A regulators. Genes in the subnetwork were enriched in certain GDM-associated hormone (thyroid hormone and oxytocin) signaling pathways. LINC00667 was positively correlated with an m6A "reader" ( YTHDF3 ; PCC = 0.95) and exhibited the highest node degree in the ceRNA network. RIP assays showed that YTHDF3 directly bind LINC00667 . We further found that MYC possessed the highest node degree in a protein–protein interaction network and competed with LINC00667 for miR-33a-5p. qPCR analysis indicated that LINC00667 , YTHDF3 and MYC levels were upregulated in the GDM placentas, while miR-33a-5p was downregulated. In a support-vector machine classifier, an m6A-related module composed of LINC00667 , YTHDF3 , MYC , and miR-33a-5p showed excellent classifying power for GDM in both the training and the testing dataset, with an accuracy of 76.19 and 71.43%, respectively. Conclusions Our results shed insights into the potential role of m6A-related lncRNAs in GDM and have implications in terms of novel therapeutic targets for GDM.

Identification of biological processes and genes for gestational diabetes mellitus

Comprehensive analysis of DNA methylation and gene expression profiles in gestational diabetes mellitus

Identification of hub genes affecting gestational diabetes mellitus based on GEO database

Predicting of Disease Genes for Gestational Diabetes Mellitus Based on Network and Functional Consistency.

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

The integrated bioinformatic analysis identifies immune microenvironment-related potential biomarkers for patients with gestational diabetes mellitus

Analysis, validation, and discussion of key genes in placenta of patients with gestational diabetes mellitus

Identification of key ubiquitination-related genes in gestational diabetes mellitus: A bioinformatics-driven study

Comprehensive Analysis of Gene Expression Profiles and DNA Methylome reveals Oas1, Ppie, Polr2g as Pathogenic Target Genes of Gestational Diabetes Mellitus

Related Genes in Pathogenesis of Gestational Diabetes Mellitus

Epigenetic Alternations of Micrornas and DNA Methylation Contribute to Gestational Diabetes Mellitus.

Increased Methylation at Differentially Methylated Region of GNAS in Infants Born to Gestational Diabetes

Identification of diagnostic biomarker in patients with gestational diabetes mellitus based on transcriptome‐wide gene expression and pattern recognition

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Gestational diabetes mellitus screening based on the gene chip technique.

Pathophysiological Role of Genetic Factors Associated With Gestational Diabetes Mellitus

Upregulation of T Cell Receptor Signaling Pathway Components in Gestational Diabetes Mellitus Patients: Joint Analysis of mRNA and circRNA Expression Profiles

Gestational diabetes mellitus: genetic factors, epigenetic alterations, and microbial composition

Serum proteins differentially expressed in gestational diabetes mellitus assessed using isobaric tag for relative and absolute quantitation proteomics

Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N6-methyladenine modification

Gene Expression Changes in Arterial and Venous Endothelial Cells Exposed to Gestational Diabetes Mellitus